Growth Hormone Use in Adults With Prader-Willi Syndrome
Sponsor: Children's Mercy Hospital Kansas City
A PHASE3 clinical study on Prader-Willi Syndrome, this trial is completed. The trial is conducted by Children's Mercy Hospital Kansas City and has accumulated 8 data snapshots since 2005. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2023 — Jul 2024 [monthly]
Completed PHASE3
-
Dec 2022 — Jan 2023 [monthly]
Completed PHASE3
-
Feb 2021 — Dec 2022 [monthly]
Completed PHASE3
Status: Unknown Status → Completed
▶ Show 3 earlier versions
-
Jan 2021 — Feb 2021 [monthly]
Unknown Status PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Unknown Status PHASE3
First recorded
Apr 2005
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Children's Mercy Hospital Kansas City
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Kansas City, United States